PUMC-MB1 is a novel group 3 medulloblastoma preclinical model, sensitive to PI3K/mTOR dual inhibitor
Article in Journal of Neuro-Oncology (April 2024)
The most recent citing publications are shown below. View all 34 publications that cite this research output on Dimensions.
Article in Journal of Neuro-Oncology (April 2024)
Article in Journal of Experimental & Clinical Cancer Research (March 2024)
Article in Oncotarget (January 2024)